KeraKlear Artificial Cornea
Corneal Blindness (Keratoconus, Scars, Dystrophies, Edema, Failed Transplants)
Investigational / CE MarkActive
Key Facts
Indication
Corneal Blindness (Keratoconus, Scars, Dystrophies, Edema, Failed Transplants)
Phase
Investigational / CE Mark
Status
Active
Company
About KeraMed
KeraMed is a specialized ophthalmology device company developing the KeraKlear Artificial Cornea, a novel implant for synthetic lamellar keratoplasty. The device is designed for implantation through a small 3.5mm incision, aiming to replace opacified corneal tissue with minimal tissue removal. While the product has achieved CE Mark certification and initial clinical use internationally, it remains an investigational device in the United States, limited to clinical studies. The company's strategy centers on advancing this technology for conditions like keratoconus, corneal scars, and failed transplants.
View full company profile